Evidence map›Paper›PMID 25626696›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2015

Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.

Bert Everaert, Cordula Felix, Jacques Koolen, Peter den Heijer, Jose Henriques, Joanna Wykrzykowska, Rene van der Schaaf, Bart de Smet, Sjoerd Hofma, Roberto Diletti and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions : 2017 revision.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
    Article
  9. Observational
  10. Article
  11. Evaluation of bifurcation stenting techniques at Catharina Hospital, Eindhoven in 2013.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
    Article
  12. Article
  13. Article
  14. Review
  15. Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2015
    Article
  16. Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Bert EveraertThoraxcenter, Erasmus Medical Centre, 's-Gravendijkwal 230, 3015 GE, Rotterdam, The Netherlands, b.everaert@erasmusmc.nl.
Cordula Felix
Jacques Koolen
Peter den Heijer
Jose Henriques
Joanna Wykrzykowska
Rene van der Schaaf
Bart de Smet
Sjoerd Hofma
Roberto Diletti
Nicolas Van Mieghem
Evelyn Regar
Peter Smits
Robert-Jan M van Geuns
Erasmus University Rotterdam · NLAcademic Medical Center · NLAmphia Ziekenhuis · NLCatharina Ziekenhuis · NLMaasstad Ziekenhuis · NLMeander Medisch Centrum · NLMedisch Centrum Leeuwarden · NLOLVG · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Percutaneous coronary interventions (PCI) have become a reliable revascularisation option to treat ischaemic coronary artery disease. Drug-eluting stents (DES) are widely used as first choice devices in many procedures due to their established good medium to long term outcomes. These permanent implants, however, do not have any residual function after vascular healing following the PCI. Beyond this initial healing period, metallic stents may induce new problems, resulting in an average rate of 2 % reinterventions per year. To eliminate this potential late limitation of permanent metallic DES, bioresorbable coronary stents or 'vascular scaffolds' (BVS) have been developed. In a parallel publication in this journal, an overview of the current clinical performance of these scaffolds is presented. As these scaffolds are currently CE marked and commercially available in many countries and as clinical evidence is still limited, recommendations for their general usage are needed to allow successful clinical introduction.

Identifiers

PMID25626696
PMCPMC4352153
OpenAlexW2060657219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.